Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients

The Institute of Molecular and Translational Medicine, Czech Republic

Status: Completed

Conditions: Circulating Tumor Cell; Non Small Cell Lung Cancer

Treatments: Diagnostic Test: Device for CTC/DTC detection

Study type: Observational

Funder types: Other

Identifiers

NCT05619562

NS10285

Details and patient eligibility

About

To determine whether the presence of circulating/disseminated tumour cells (CTCs/DTCs) in the blood and bone marrow of the resectable lung cancer (NSCLC) patients is a negative prognostic factor, and to find correlations with other clinical/pathological disease characteristics.

Enrollment: 166 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Non-small cell lung cancer, non-metastatic

Exclusion criteria

Prior neoadjuvant chemoradiotherapy Prior lung cancer Cancer duplicity